Policymakers and healthcare providers have an urgent need for reliable scientific data if they are to effectively provide for multimorbidity in an ageing population. Thanks to routinely collected healthcare data (RCHD) from English hospitals, accessed through the HDR UK CALIBER phenotype library, Canadian neurologists have worked with UCL on new research into the relationship between epilepsy, dementia, frailty and mortality in older people.
Dementia and epilepsy are placing a growing burden on individuals and healthcare systems. Both are identified as public health priorities by the World Health Organization (WHO). A better understanding of the extent and impact of comorbid epilepsy and dementia is essential for planning and for personal care. Likewise, delivering better care demands improved knowledge of the risk factors associated with incident dementia and the impact of frailty and dementia on mortality in older adults with epilepsy.
Researchers from the University of Calgary collaborated with the Institute of Health Informatics at UCL, and others, to conduct a study based on a matched cohort of 11,307 adults aged 65 or above with and without epilepsy. The health informatics was led by Dr Arturo Gonzalez-Izquierdo, a UCL Senior Health Data Scientist. According to Dr Gonzalez-Izquierdo the availability of RCHD from English electronic health records was fundamental, as was CALIBER, which provided what he described as “a beautiful research dataset with very long and detailed patient’s health-trajectories”.
The findings, published in the July 2021 edition of Epilepsy and Behavior, confirm that the odds of having dementia are 7.39 [95% CI 5.21–10.50] times higher in older adults with incident epilepsy. Older adults with epilepsy had higher odds of mild, moderate and severe frailty. A higher comorbidity burden is a risk factor for dementia, while prevalent dementia and increasing frailty are associated with mortality.
An accumulation of deficits among older adults with epilepsy, rather than one specific factor, appears to lead to an increased risk of mortality. The researchers suggest that screening for frailty in older adults with epilepsy could be beneficial.
Impact and outcomes
The research is intended as a foundation for further research and to provide firm evidence for future healthcare policy and practice – enabling better management of individual patients and wider healthcare costs. It also demonstrates the value of health data science in addressing pressing healthcare needs through the use of large, high quality data sets.
HDR UK aims and priorities
HDR UK has a series of priorities to maximise the impact of health data research in tackling pressing healthcare needs. This research addressed several:
- Improving public health
- Better care
- Human phenome (improving)
- Applied analytics (improving)
It also fits HDR UK’s priorities of:
- Improving healthy life expectancy for people living with a common disease
- Developing and applying advanced health data science to address major challenges
The paper is available from Epilepsy and Behavior.
Contact Dr Gonzalez-Izquierdo at email@example.com
The HDR UK Phenotype Library celebrates reaching 1000 phenomes
30 August 2022
The milestone marks the Library as the largest national resource for information, tools and phenotyping algorithms to allow researchers to harness data held in Electronic Health Records.
Cardiovascular outcomes associated with treatment of type 2 diabetes in patients with ischaemic heart failure
1 July 2022
Metformin is a commonly used diabetes drug that is also thought to benefit people who have heart failure. Researchers studied large-scale health records to understand the impact of diabetes...
Patient-centric characterization of multimorbidity trajectories in patients with severe mental illnesses: A temporal bipartite network modeling approach
21 June 2022
People with severe mental illness have a lower life expectancy and a higher risk of physical conditions. To improve how these comorbidities can be detected and predicted, researchers have used...